| Literature DB >> 32123595 |
Swati Chauhan1, Neha Jain1, Upendra Nagaich1.
Abstract
Nanodiamonds are novel nanosized carbon building blocks possessing varied fascinating mechanical, chemical, optical and biological properties, making them significant active moiety carriers for biomedical application. These are known as the most 'captivating' crystals attributed to their chemical inertness and unique properties posing them useful for variety of applications in biomedical era. Alongside, it becomes increasingly important to find, ascertain and circumvent the negative aspects associated with nanodiamonds. Surface modification or functionalization with biological molecules plays a significant role in managing the toxic behavior since nanodiamonds have tailorable surface chemistry. To take advantage of nanodiamond potential in drug delivery, focus has to be laid on its purity, surface chemistry and other considerations which may directly or indirectly affect drug adsorption on nanodiamond and drug release in biological environment. This review emphasizes on the basic properties, synthesis techniques, surface modification techniques, toxicity issues and biomedical applications of nanodiamonds. For the development of nanodiamonds as an effective dosage form, researchers are still engaged in the in-depth study of nanodiamonds and their effect on life interfaces.Entities:
Keywords: Biochemical application; Diamondoids; Drug targeting; Nanomedicine; Surface functionalization
Year: 2019 PMID: 32123595 PMCID: PMC7037532 DOI: 10.1016/j.jpha.2019.09.003
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Fig. 1Schematic representation of nanodiamond classification.
Fig. 2Pictorial representation of properties of nanoparticles and diamonds.
Fig. 3Basic structure of nanodiamonds with surface functional groups.
Fig. 4Diagrammatic illustration of nitrogen-vacancy (N-V) centers in nanodiamonds.
Fig. 5Diagrammatic presentation of nanodiamonds synthesis via detonation technique.
Fig. 6Flowchart representation of nanodiamonds synthesis via chemical vapor deposition technique and ultrasonic technique.
Fig. 7In vitro cytotoxicity (MTT) assay for nanodiamonds.
Fig. 8Model organisms used for in vivo studies with nanodiamonds.
In vivo studies conducted with nanodiamonds.
| S.No. | Parameter for biocompatibility | Observations based on parameters | Model organism | Nanodiamond type with size | In vivo study results |
|---|---|---|---|---|---|
| 1. | Survival | 1. Cytotoxicity and in vivo toxicity | 1. Human embryonic kidney 293 (HEK293) cells | FND (4 nm) | Chemically surface functionalized (-OH, -NH2 or -CO2H) ND related cytotoxicity and in vivo toxicity of ND were prepared. They used two model systems viz. human embryonic kidney 293 (HEK293) cells and |
| 2. Mortality rate | Bivalvae | DND (4–6 nm) | 100% mortality when exposed to ND solutions of 10 g/L [ | ||
| 2. | Morphology | 1. Embryonic development | Zebrafish embryo | DND (100 nm) | A concentration dependent higher malformation induction after ND-COOH micro injection [ |
| Cynomolgus monkey ( | DND | Some substantial abnormalities in monkey heart and liver at higher doses. Mild abnormalities at normal doses. | |||
| Rat ( | No abnormal liver or kidney function histological changes. | ||||
| Xenograft SCID mice | ND-paclitaxel | Preservation of anticancer activities on the induction of mitotic blockage and apoptosis [ | |||
| 3. | Biodistribution | Accumulation | Rat | NDs | 1. Radio labeled diamond nanoparticles gets accumulated majorly in lung, spleen and liver and finally gets excreted into the urinary tract. 2. An inflammatory response in the lungs and high dose- dependent retention of NDs in the lung [ |
| NDs retention and accumulation in the macrophages present in the liver [ | |||||
| Mice | FND | Accumulation in the axillary lymph nodes [ | |||
| 4. | Metabolism | 1. Biochemical parameter | Rats and monkeys | ND | 1. Some histological alterations but no organ dysfunction. 2. Some changes in blood biochemical parameters affecting the liver function and lipid metabolism, but no signs of cell destruction [ |
| Murine | ND | Increased activity of glutathione S- transferase on 7 day and catalase on 14 day were observed respectively [ |
Fig. 9Illustration of several schemes for the surface functionalization of nanodiamonds.
Recent investigations regarding Nanodiamonds for cancer therapy.
| S.No. | Year | Methodology adopted for cancer investigation | In vitro and in vivo results |
|---|---|---|---|
| 1. | 2014 | Cellular uptake studies of nanodiamond doxorubicin complex (NDDOX) via laser scanning confocal microscopy using HepG2 cells. | Slow and sustained drug release characteristics compared with free doxorubicin. Survival rate with NDDOX was four times greater than that free doxorubicin. Histopathological analysis revealed non-toxicity of NDs and NDDOX to kidney, liver, or spleen in contrast with the well-known toxic effects of free doxorubicin [ |
| 2. | 2010 | Nanodiamonds-paclitaxel conjugation for cancer therapy and evaluated by atomic force microscope and nuclear magnetic resonance spectroscopy. | Reduction in cell viability in the A549 human lung carcinoma cells. ND-paclitaxel was taken into lung cancer cells and was located in the microtubules and cytoplasm of A549 cells observed by flow cytometer analysis and confocal microscopy respectively. Tumor growth and formation of lung cancer cells were also blocked in xenograft SCID mice [ |
| 3. | 2015 | Self-assembled nanodiamond-lipid hybrid particles (NDLPs) were used for cell-targeted imaging and therapy of triple negative breast cancers. | Highly biocompatible particles providing cell-specific imaging, tumor retention of ND-complexes, preventing epirubicin toxicities and mediating regression of triple negative breast cancers [ |
| 4. | 2014 | Epirubicin was used to synthesize stable nanodiamond–drug complex. | Increased endocytic uptake and enhanced tumor cell retention. Improved impairment of secondary tumor formation [ |
| 5. | 2015 | Surface irradiated nanodiamonds (INDs) were grafted with polyethylene glycol (PEG) to improve its stability and circulation time in blood. | INDs accumulate in tumors and completely delineate the entire tumor within 10 h [ |
Patents granted for Nanodiamonds as drug delivery system.
| S.No. | Patent No./Application No. | Title | Research work done |
|---|---|---|---|
| 1. | US 20100129457A1 | Nanodiamonds enhanced drugs | Efficacy of drugs like analgesics, cholesterol reducing drugs and other substances are increased by attaching them (covalently) and the functional groups to nanodiamond surface [ |
| 2. | US 8753614 B2 | Nanodiamond UV protectant formulations | A cosmetic or sunscreen preparation comprising diamond nanoparticle in a physiologically compatible medium was prepared [ |
| 3. | US 9227089 B1 | Skin treatment for promoting hair growth | Nanodiamond is used as a mineral carrier for infusing the blood product composition [ |
| 4. | US 20100305309 A1 | Nanodiamond particle complexes | Soluble complexes of nanodiamond particles and therapeutic agents like insoluble therapeutics, anthracycline, tetracycline compounds, nucleic acids, proteins, etc were prepared [ |
| 5. | US 7294340 B2 | Healthcare and cosmetic compositions containing nanodiamond | Compositions like deodorants, toothpastes, shampoos, antibiotics, dermal strips, DNA test strips, skin cleansers were explored [ |
| 6. | US 9248383 B2 | Composite materials containing nanoparticles and their use in chromatography | Porous inorganic/organic hybrid particles were embedded with nanoparticles selected from oxides or nitrides [ |
| 7. | US 9283657 B2 | Method of making a diamond particle suspension and method of making a polycrystalline diamond article therefrom | Polycrystalline diamond compact was formed using substantially homogeneous suspension of nanodiamond particles and microdiamond particles [ |
| 8. | US 8888736 B2 | High shear application in medical therapy | Method comprising mixing a therapeutic gas or a therapeutic liquid or a combination thereof and a liquid carrier in a high shear device to produce a dispersion [ |
| 9. | US 8293216 B2 | Cleaning oral care compositions | An oral care composition comprising a fused silica abrasive offering improved cleaning [ |
| 10. | US 7569205 B1 | Nanodiamond fractional and the products thereof | Nanodiamonds were processed to fractionate the detonation nanodiamonds, forming a combination of detonation nanodiamonds and a solvent [ |